Considering cancer as the leading cause of death (age and sex combined) in many industrialized countries, it is not surprising that 714X was requested 90% of the time to support patients with this disease.
Nine percent (9%) of requests were made for autoimmune diseases (eg. lupus erythematosus, rheumatoid arthritis, mastocytosis, etc…).
For the past 10 years, many requests for a preventative use of 714X (1%) were received. This tendency is growing with the realization for the necessity to be proactive in the management of our health.
Nine percent (9%) of requests were made for autoimmune diseases (eg. lupus erythematosus, rheumatoid arthritis, mastocytosis, etc…).
For the past 10 years, many requests for a preventative use of 714X (1%) were received. This tendency is growing with the realization for the necessity to be proactive in the management of our health.